ENDURANT® ENEW2020C82ERecalls & reported problems
Medtronic, Inc. · STENT GRAFT ENEW2020C82E ENDURANT EXT · Class 3 · Implant
All models of ENDURANT (46)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00613994762146), received between Jul 19, 2017 and Aug 17, 2021 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Leak/Splash” (4 reports).
6 other recalls cover devices cleared under the same FDA submission (P100021); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Leak/Splash4
- Occlusion Within Device1
Patient problems
- Abdominal Pain1
- Injury1
- Insufficient Information1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryAug 17, 2021Leak/Splash; Leak/Splash
AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN AN UNKNOWN ENDOVASCULAR PROCEDURE. IT WAS REPORTED THAT A CT WAS PERFORMED 10 YEARS LATER WHERE A ENDOLEAK TYPE 3A WAS OBSERVED. ADDITIONALLY, A DISTAL LEFT COMMON ILIAC ANEURYSM HAD DEVELOPED IN THE INTERIM. IT WAS STATED THAT A INADEQUATE OVERLAP OF 10-13MM BETWEEN THE ENLW1620C93E RIGHT LIMB AND ENEW2020C82E RIGHT DISTAL EXTENSION WAS NOTED DURING THE INITIAL FOLLOW-UP PERFORMED ONE MONTH POST INDEX PROCEDURE. AN INITIAL ANGIOGRAM CONFIRMED A COMPLETE DIS-ASSOCIATION OF THE RIGHT LIMB AND DISTAL EXTENSION, INTERVENTION WAS PERFORMED APPROXIMATELY 6 WEEKS POST CT WHERE AN ETEW2020C82E ILIAC EXTENSION WAS ADDITIONALLY IMPLANTED TO SPAN THE GAP AND SUCCESSFULLY RESOLVE THE TYPE 3A LEAK A NON-MEDTRONIC DEVICE WAS THEN DEPLOYED INTO THE LEFT INTERNAL ILIAC ARTERY, AFTER WHICH A ETLW1610C199E LIMB WAS DELIVERED INTO THE ETLW1624C93E LEFT ILIAC DEVICE TO EXTEND THE SEAL BEYOND THE ILIAC ANEURYSM AND ACHIEVE SEAL IN THE PROXIMAL LEFT EXTERNAL ILIAC ARTERY. AN ANGIOGRAM CONFIRMED ADEQUATE DISTAL SEAL AND SUCCESSFUL OCCLUSION OF THE LEFT HYPO, IT WAS DECIDED THE PROXIMAL OVERLAP OF THE ETLW1610C199E NEEDED TO BE EXTENDED WITH A ETLW1616C124E
Patient problems: Insufficient Information
MAUDE report 12330007 ↗InjuryApr 16, 2019Leak/Splash; Leak/Splash
AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 55MM ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT THE PATIENT PRESENTED EMERGENTLY WITH ABDOMINAL PAIN APPROXIMATELY SEVEN YEARS LATER AND CT SHOWED A TYPE IB ENDOLEAK ON THE RIGHT. IT WAS NOTED THAT THE RIGHT COMMON ILIAC ARTERY HAD DILATED AND NOW MEASURED 30MM. THE ORIGINAL IMPLANT ON THIS SIDE HAD A 20MM DIAMETER. THE PHYSICIAN COILED THE RIGHT HYPOGASTRIC AND THEN IMPLANTED THREE LIMBS ON THE RIGHT SIDE. IT WAS NOTED THAT THE LEFT SIDE ILIAC DIAMETER HAD ENLARGED AND WAS NOW 20MM WITH A 13MM DIAMETER STENT GRAFT PREVIOUSLY IMPLANTED, SO ANOTHER EXTENSION WAS ALSO IMPLANTED HERE. THE FINAL ANGIOGRAM SHOWED RESOLUTION OF THE TYPE IB ENDOLEAK AND GOOD PERFUSION TO THE LEFT HYPOGASTRIC ARTERY. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS ANATOMY RELATED DUE TO NATURAL HISTORY OF ANEURYSM DISEASE. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Abdominal Pain
MAUDE report 8517505 ↗MalfunctionJun 15, 2018Leak/Splash; Occlusion Within Device; Leak/Splash; Occlusion Within Device
AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM OF AN UNKNOWN SIZE. IT WAS REPORTED THAT A CT EXAM PERFORMED APPROXIMATELY 7 YEARS POST INDEX PROCEDURE, SHOWED THAT THERE WAS THROMBUS OF THE RIGHT LIMB (B)(4) AND A TYPE III SEPARATION IN THE LEFT LIMB BETWEEN THE BIFURCATE AND LEFT LIMB EXTENSION. THESE LIMBS WERE NOTED ON CT TO BE COMPLETELY OCCLUDED. THE CT ALSO SHOWED ANEURYSM EXPANSION. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT IS CURRENTLY UNKNOWN. IT WAS REPORTED THE EVENT IS NOT RESOLVED. NO ADDITIONAL CLINICAL SEQUALAE WERE REPORTED AND THE PATIENT WILL BE MONITORED BY THEIR PHYSICIAN.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7605732 ↗InjuryJul 19, 2017Leak/Splash; Leak/Splash
AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A GREATER THAN 5CM DIMETER ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT DURING A RECENT FOLLOW UP THE CT DEMONSTRATED A DISTAL TYPE I ENDOLEAK WITH ANEURYSM SAC EXPANSION. THE PHYSICIAN IMPLANTED ANOTHER ILIAC LIMB DISTALLY AND THE DISTAL TYPE I ENDOLEAK WAS RESOLVED. PER THE PHYSICIAN, THE CAUSE OF THE DISTAL TYPE I ENDOLEAK WAS PATIENT ANATOMY RELATED, AORTIC REMODELING. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Injury
MAUDE report 6726997 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P100021. One submission often covers many models, so check the product and lot details in each record.
- Z-0291-2022 · Oct 15, 2021 · Open, ClassifiedEndurant II Stent Graft System REF/Description: ETBF2513C145EE STENT GRAFT ETBF2513C145EE ENDUR II BIF ETBF2820C166EE STENT GRAFT ETBF2820C166EE ENDUR II BIF ETBF2820C166EE STENT G
- Z-0290-2022 · Oct 15, 2021 · Open, ClassifiedEndurant Stent Graft System REF/Description: ENTF2525C70EE STENT GRAFT ENTF2525C70EE ENDURANT TUBE
- Z-0292-2022 · Oct 15, 2021 · Open, ClassifiedEndurant IIs Stent Graft System REF/Description: ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STEN
- Z-2135-2021 · Jun 7, 2021 · Open, ClassifiedEndurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infra
- Z-2136-2021 · Jun 7, 2021 · Open, ClassifiedMedtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoili
- Z-1543-2017 · Feb 27, 2017 · TerminatedEndurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems Model Numbers: ETBF2516C145E ETBF2516C166E ETBF2316C145E ETBF2313C145E ETBF2513C166E ETBF2313C166E ETBF2316C166
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page